Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma [NA]
ClinicalTrials.gov update on survival related to feeding artery obliteration by transarterial chemoembolization for unresectable hepatocellu…
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... [Phase 2]
Phase II, multi-histology trial of fostamatinib disodium (R935788) in advanced colorectal, non-small cell lung, head and neck, hepatocellula…
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: Proton Beam Therapy for Treatment of Hepatocellular Carcinoma [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 proton beam therapy for hepatocellular carcinoma that has completed, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2012-08-10Clinical Trial Update: Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation [Phase 2]
A Phase 2 trial conducted by Conatus Pharmaceuticals evaluated the safety and efficacy of a caspase inhibitor (emricasan) in patients underg…
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures
A clinical trial update reports the feasibility findings of a minimally invasive image-guided surgery system for hepatic procedures in liver…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Proton Therapy and Bevacizumab for Primary Liver Tumors [Phase 1]
Phase 1 study of proton therapy with bevacizumab for primary liver tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin [Phase 1]
Phase 1 trial evaluating hepatic arterial infusion of oxaliplatin, fluorouracil, leucovorin, and bevacizumab in liver cancer and other advan…
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study [Phase 2]
Phase 2 multicentre randomized trial evaluating everolimus for immunosuppression in de novo liver transplantation.
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC) [Phase 2]
Phase II trial evaluating vandetanib plus best supportive care in inoperable hepatocellular carcinoma has completed, with results posted in …
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma [Phase 2, Phase 3]
An ongoing randomized trial in unresectable hepatocellular carcinoma compares transarterial chemoembolization (TACE) alone versus TACE plus …
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer [Phase 2]
Phase 2 trial evaluating preoperative radiation therapy with fluorouracil for primary or recurrent cholangiocarcinoma (bile duct cancer) and…
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) [Phase 1]
A Phase 1 safety study of ARQ 197 (tivantinib) in cirrhotic patients with hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics and preliminary efficacy of a Tor Kinase Inhibitor in patients with advanced…
-
CLINICAL_TRIALS trial_result · 2012-07-03Clinical Trial Update: Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]
Phase I/II study of Z-208 in advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Fluid Optimization in Liver Surgery
This document reports that the clinical trial evaluating perioperative fluid optimization during liver cancer surgery has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery [Phase 2]
A Phase 2 trial of sunitinib in patients with unresectable liver cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating epirubicin in combination with celecoxib for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 study of the anti-CTLA-4 monoclonal antibody CP-675,206 for advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis [Phase 4]
Phase 4 clinical trial update evaluating transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor th…
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Combination of Transcatheter Arterial Chemoembolization (TACE) and Sorafenib for Patients With Unresectable Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 trial evaluating transarterial chemoembolization plus sorafenib for unresectable hepatocellular carcinoma has completed. No efficacy…
-
CLINICAL_TRIALS trial_result · 2012-05-25Clinical Trial Update: TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 trial exploring transarterial chemoembolization (TACE) combined with sorafenib for unresectable hepatocellular carcinoma. The update…
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: DX-8951f in Treating Patients With Biliary Cancer [Phase 2]
A Phase 2 trial of the investigational drug DX-8951f in biliary tract cancers has completed, evaluating extrahepatic cholangiocarcinoma and …
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: DX-8951f in Treating Patients With Liver Cancer [Phase 2]
A Phase 2 trial of DX-8951f for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma [Phase 2]
A Phase 2 study comparing SIR-Spheres Y-90 resin microspheres with transarterial chemoembolisation in patients with unresectable hepatocellu…
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001 [Phase 2]
Phase 2 trial evaluating antiangiogenic therapy with bevacizumab and everolimus for hepatocellular carcinoma has been completed.